Part 2.911 d.7 FCC US Agent Letter of Attestation

File Info : application/pdf, 1 Pages, 311.45KB

Array
(
    [0] => Array
        (
            [url_sha] => 47e62b34ce97bc2aad2b76f209e0a1f270fad21729f08d95dfe3e9710de7bdbf
            [source] => fccid
            [url] => https://apps.fcc.gov/eas/GetApplicationAttachment.html?id=8128702
            [href_text] => Part 2.911 d.7 FCC US Agent Letter of Attestation
            [href_description] => LifeScan Europe GmbH Z03 Blood Glucose Monitoring System 2ACT5-Z03 2ACT5Z03 z03
            [http_status] => 200
            [http_lastmod] => 0000-00-00 00:00:00
            [http_contenttype] => application/pdf
            [http_filename] => GetApplicationAttachment.html?id=8128702
            [http_size] => 318927
            [file_sha256] => a433fc52bf90e021bee7ecf40c6ace8594756220cb62a16ede0f27ce2b58e322
            [domain] => document.fccid
        )

)

Array
(
    [0] => Array
        (
            [id] => 8128702
            [file_sha256] => 
            [applicationId] => MHJvyY9JmEIjZiAV4KPeVg==
            [description] => Part 2.911 d.7 FCC US Agent Letter of Attestation
            [shortTermConfidential] => No
            [permanentConfidential] => No
            [supercede] => No
            [exhibitType] => Attestation Statements
            [fileType] => Adobe Acrobat PDF
            [displayType] => pdf
            [fileSize] => 318929
            [submissionDate] => 2025-03-19 00:00:00
            [dateAvailable] => 2025-03-19 00:00:00
            [creationDate] => 
            [producer] => 
            [modDate] => 
            [title] => 
            [creator] => 
            [author] => 
            [pages] => 
            [realSize] => 
            [html] => 0
            [png] => 0
            [txt] => 0
            [version] => 0
            [source] => 0
            [fccId] => 2ACT5-Z03
            [cleanFccId] => 2ACT5Z03
            [exif] => 0
        )

)